InsidersTradesSigma
Track the 特宝生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 特宝生物 has published 5 insider filings. Market capitalisation: €23.7bn. The latest transaction was reported on 15 July 2024 (Sale). Among the most active insiders: 王君业. All data is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,672 of 29,063 companies
69.3
score / 100
Value46
Quality93
FCF yld2.0%
Earn yld4.3%
EV/EBITDA18.4x
ROE32%
Gross mgn93%
Net mgn28%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2024
Declarations5 total
5 of 5 declarations
关于 特宝生物
特宝生物是一家在上海证券交易所上市的医疗保健和制药公司。它专注于生物制药产品的开发和商业化。